An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows
An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments—by lowering levels of a brain protein called tau, researchers reported Tuesday.
12 hours ago
0
4









